RafTR Mouse Product
[…] nervous system (Neurofibromas). These tumours are initiated by Schwann cells in which the small GTPase Ras becomes basally more active. Raf is one of the key downstream effectors of Ras […]
[…] nervous system (Neurofibromas). These tumours are initiated by Schwann cells in which the small GTPase Ras becomes basally more active. Raf is one of the key downstream effectors of Ras […]
conditionally expressed an oncogenic K-rasD12 allele in the small intestine of adult mice either alone or in the context of Apc deficiency.
Malme-3M is a malignant human melanoma cell line that displays fibroblast-like morphology and grows in mixed culture (adherent-suspension). This cell line has been shown to be dependent upon micropthalmia-associated transcription […]
SK-MEL-2 is one of a series of melanoma cell lines established from patient-derived tumour samples. This cell line expresses wildtype B-Raf and mutant N-Ras (Q61R).
SK-MEL-24 is one of a series of melanoma cell lines established from patient-derived tumour samples. This cell line expresses wildtype B-Raf and wildtype N-Ras.
[…] melanocytes established from patient-derived tumour samples. This cell line expresses mutant B-Raf (V600E) and wildtype N- Ras and were isolated from the skin of a 29-year-old, White male patient with melanoma.
[…] study signalling pathways in breast cancer. They can be grown in 3D culture. The addition of the H-Ras12 simulates breast cancer as 50% of breast cancers display increased H- Ras activity.
[…] KRAS mutant colon carcinoma cell line. In some immunoresistant tumours, PD-L1 expression is upregulated by RAS activation. Via the MEK pathway, the MK2 kinase phosporylates and inhibits TTP, which negatively […]
[…] for both estrogen receptor isoforms and progesterone receptor B, presents mutations in PTEN and K- Ras genes, one tumor suppressor and one oncogene frequently mutated in endometrial cancers. Cell line […]
[…] that displays epithelial morphology and grows in adherent culture. This cell line expresses mutant K- Ras (G12D) and has homozygous deletions in the CDH6 and CDKN2A genes. These cells do […]
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.